CTOs on the Move

Center for Diagnostic Imaging

www.mycdi.com

 
What`s best for each patient drives our business. Through Center for Diagnostic Imaging`s national network, including Insight Imaging, we partner with healthcare providers to do what we do best — manage and deliver high-quality medical imaging (i.e. MRI, PET/CT, etc.) and related services (i.e. injections for pain) to enhance patient care. CDI offers the highest quality of care through a network of outpatient imaging centers and mobile facilities in more than thirty states. Headquartered in Minneapolis, Minnesota; the organization serves more than one million patients a year through a diverse set of customers including healthcare providers, managed care organizations, hospitals, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.mycdi.com
  • 5775 Wayzata Blvd Ste 845
    Minneapolis, MN USA 55416
  • Phone: 763.398.4650

Executives

Name Title Contact Details
Glenn Galloway
Chief Information Officer Profile
Linda Bagley
Chief Information Officer Profile

Similar Companies

New Life Brace and Limb

New Life Brace and Limb is a Webster, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oncology Services International

Our mission is to form long term trusting relationships with healthcare providers to help them deliver outstanding patient outcomes and experiences. We will never compromise quality in creating value through cost-effective healthcare technology solutions. From the services we provide to the equipment and parts we deliver, we will help our customers meet the challenges of providing high quality care while containing cost.

Urocare Products

Urocare Products, Inc. is a Pomona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lifelines Neurodiagnostic Systems

Lifelines Neurodiagnostic Systems is a Troy, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

www.biosig.com

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.